← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lexeo Therapeutics, Llc
New York, NY
$2,925,591
Total funding
5
Grants
Funding over time
peak $1.6M · FY2018–20$2M$1.5M$1M$500K$0
'18
'19
'20
Funding mix
By agency
NIH$2,925,591 · 5
By mechanism
R42$1,724,070 · 1
R41$1,201,521 · 4
Investigators at Lexeo Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Oxidation-resistant Anti-protease Therapy$1,157,532
R42 · FY2019 · HL
CNS Gene Therapy for CLN2 Disease Using Parallel Multiple Routes of Administration$499,916
R41 · FY2020 · NS
Oxidation-resistant Anti-protease Therapy$341,571
R42 · FY2020 · HL
Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency$252,042
R41 · FY2020 · AA
Gene Therapy to Prevent Esophageal Cancer Associated with Aldehyde Dehydrogenase Deficiency$224,970
R41 · FY2019 · AA
Oxidation-resistant Anti-protease Therapy$224,967
R42 · FY2018 · HL
Gene Therapy to Protect the Lung from Oxidant Stress$224,593
R41 · FY2019 · HL